Esperion Theraptc (ESPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 403,135 | 332,314 | 116,334 | 75,475 | 78,447 |
| Cost of Goods | 129,224 | 68,601 | 43,267 | 26,967 | 14,217 |
| Gross Profit | 273,911 | 263,713 | 73,067 | 48,508 | 64,230 |
| Operating Expenses | 213,862 | 209,912 | 228,897 | 228,976 | 291,177 |
| Operating Income | 60,273 | 54,402 | -155,563 | -179,501 | -226,730 |
| Interest Expense | 84,604 | 59,251 | 58,976 | 56,810 | 46,353 |
| Other Income | 3,490 | -46,896 | 5,291 | 2,652 | 3,975 |
| Pre-tax Income | -20,841 | -51,745 | -209,248 | -233,659 | -269,108 |
| Income Tax | 1,841 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -22,682 | -51,745 | -209,248 | -233,659 | -269,108 |
| Net Income | $-22,682 | $-51,745 | $-209,248 | $-233,659 | $-269,108 |
| EPS Basic Total Ops | -0.11 | -0.28 | -2.03 | -3.52 | -9.31 |
| EPS Basic Continuous Ops | -0.11 | -0.28 | -2.03 | -3.52 | -9.31 |
| EPS Diluted Total Ops | -0.11 | -0.28 | -2.03 | -3.52 | -9.31 |
| EPS Diluted Continuous Ops | -0.11 | -0.28 | -2.03 | -3.52 | -9.31 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.01 | -2.03 | -3.52 | -9.31 |
| EBITDA(a) | $63,385 | $55,963 | $-154,114 | $-177,101 | $-224,485 |